Further studies are needed to validate the findings identified in silico, and to lighten the association of these results with clinicopathological findings to elucidate the mechanism of EGFL7 in the genesis of CRC, in order to propose adequate treatment approaches for colorectal cancer using EGFL7 as possible biomarker. The gene discussed is EGFL7; the disease is colorectal cancer.